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Abstract
Objective–Biologics are highly effective in ankylosing spondylitis (AS). In this self-
controlled study, we assessed the additive value of complex physiotherapy in decreasing chest
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pain and tenderness and improving respiratory function in AS patients treated with tumor
necrosis factor α (TNF-α) inhibitors.
Patients and methods–The trial consisted of 2 parts. In study I, clinical data of AS patients
with (n=55) or without biological therapy (n=20) were retrospectively analyzed and
compared. Anthropometrical data, duration since diagnosis and patient assessment of disease
activity, pain intensity, tender points, sacroiliac joint involvement determined by X-ray,
functional condition, and physical activity level were recorded. Subjective, functional, and
physical tests were performed. In study II, 10 voluntary patients (6 men and 4 women, age
52.4±13.6 years) with definite AS and receiving anti-TNF therapy were recruited. It was a
prospective, non-randomized physiotherapeutic trial. BASFI (Bath Ankylosing Spondylitis
Functional Index), BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), modified
Schober Index, occiput-to-wall distance, and fingertip-to-floor distance were evaluated.
Forced vital capacity, forced 1-s expiratory volume, peak expiratory flow, and maximum
voluntary ventilation were recorded. Furthermore, typical tender points were recorded. A
targeted physiotherapy program was conducted twice a week for 12 weeks and all above
parameters were recorded at baseline and after 12 weeks.
Results–Differences in patient assessment of disease activity (p=0.019) and pain intensity
(p=0.017) were found in study I. Pain and tenderness of the thoracic spine were observed
in both groups. Back pain without biologic therapy was slightly higher than other group.
In study II, we found that patient assessment of disease activity and pain intensity
significantly improved after the physical therapy program (p=0.002 and p<0.001). BASFI
and BASDAI increased after treatment (p=0.004 and p<0.001). The finger-to-floor
distance, chest expansion, and modified Schober index increased (p=0.008, p<0.001, and
p=0.031, respectively). The respiratory functional parameters showed a tendency towards
improvement.
Conclusion–AS patients already receiving biological therapy may benefit from additional
targeted physiotherapy. Physical therapy may be of important additive value in AS patients
being treated with biological. The exercise program presented here showed an improvement
in functional parameters as well as spine and chest mobility, thereby enhancing the favorable
effects of biological therapy.
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Behandlung der ankylosierenden Spondylitis mit Biologika
und gezielter Physiotherapie
Positive Wirkung auf Thoraxschmerz, verminderte Thoraxbeweglichkeit und
Atemfunktion
Zusammenfassung
Ziel–Biologika sind hochwirksam bei ankylosierender Spondylitis (AS). In dieser
eigenkontrollierten Studie wurde der Mehrwert einer komplexen Physiotherapie zur
Linderung von Thoraxschmerzen und -empfindlichkeit sowie zur Verbesserung der
Atemfunktion bei AS-Patienten untersucht, welche mit Tumornekrosefaktor-alpha(TNF-α)-
Inhibitoren behandelt wurden.
Patienten und Methoden–Die Studie bestand aus 2 Teilen. In Studie I wurden die
klinischen Daten von AS-Patienten mit (n=55) oder ohne (n=20) biologische Therapie
retrospektiv ausgewertet und verglichen. Anthropometrische Daten, Zeit seit Diagnose
und Patientenbeurteilung der Krankheitsaktivität, Schmerzintensität, Druckpunkte,
Beteiligung des Sakroiliakalgelenks gemäß Röntgenbild, Funktionszustand und körperliches
Aktivitätsniveau wurden dokumentiert. Es wurden subjektive, funktionelle und körperliche
Tests durchgeführt. In Studie II wurden 10 freiwillig teilnehmende Patienten (6 Männer,
4 Frauen, Alter: 52,4±13,6 Jahre) mit gesicherter AS und unter Anti-TNF-Therapie
aufgenommen. Es handelte sich um eine prospektive nichtrandomisierte physiotherapeutische
Studie. BASFI (Bath Ankylosing Spondylitis Functional Index), BASDAI (Bath Ankylosing
Spondylitis Disease Activity Index), modifizierter Schober-Index, Hinterkopf-Wand-Abstand
und Finger-Boden-Abstand wurden untersucht. Auch die forcierte Vitalkapazität, das forcierte
expiratorische 1-s-Volumen, der expiratorische Spitzenfluss und die maximale willkürliche
Ventilation wurden dokumentiert. Außerdem wurden typische Druckpunkte aufgezeichnet.
Ein gezieltes Physiotherapieprogramm wurde 2-mal pro Woche durchgeführt und sämtliche
genannten Parameter zu Beginn der Studie und nach 12 Wochen dokumentiert.
Results–In Studie I stellten sich Unterschiede bei der Patientenbeurteilung der
Krankheitsaktivität (p=0,019) und Schmerzintensität (p=0,017) heraus. Schmerz
und Empfindlichkeit der Brustwirbelsäule wurden in beiden Gruppen beobachtet.
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Rückenschmerzen ohne biologische Therapie waren etwas stärker als in der anderen Gruppe.
In Studie II stellte sich heraus, dass die Patientenbeurteilung der Krankheitsaktivität und
Schmerzintensität sich signifikant nach dem Physiotherapieprogramm besserte (p=0,002 bzw.
p<0,001). BASFI und BASDAI stiegen nach Behandlung an (p=0,004 bzw. p<0,001). Der
Finger-Boden-Abstand, die Thoraxausdehnung und der modifizierte Schober-Index nahmen
zu (p=0,008; p<0,001 bzw. p=0,031). Die funktionellen Atemparameter wiesen eine Tendenz
in Richtung der Verbesserung auf.
Schlussfolgerung–AS-Patienten, die bereits eine biologische Therapie erhalten, ziehen
möglicherweise einen Nutzen aus zusätzlicher gezielter Physiotherapie. Für AS-Patienten
unter Biologikatherapie kann die Physiotherapie einen bedeutenden zusätzlichen Wert
darstellen. Das hier vorgestellte Trainingsprogramm führte zu Besserung funktioneller
Parameter sowie der Wirbelsäulen- und Thoraxbeweglichkeit, somit konnten die günstigen
Wirkungen der biologischen Therapie verstärkt werden.
Schlüsselwörter
Atemübungen · Physiotherapie · Biologische Therapie · Anti-TNF-Therapie · Atmung
Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory disease involving entheses and joints
around the spine. The most widespread involvement of the respiratory system occurs when
this pathological process gives rise to chest pain with kyphosis and decreased chest expansion.
During healing of the inflammatory process, calcification occurs, leading to rigidity with
a consequent decrease of chest expansion—which is exacerbated by the kyphotic spinal
structure and intercostal muscles inefficiency—and changed respiratory function [1, 2, 3, 4].
__Patients with chest pain and without accompanying respiratory symptoms (dyspnea or
cough), suffer from primary musculoskeletal involvement. With subsequent involvement of
the thoracic spine and occurrence of enthesopathy at the costosternal and manubriosternal
joints, patients may experience chest pain when coughing or sneezing [5, 6, 7].
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__Since mostly the structural changes of the chest wall trigger chest pain, the cause can
be obviously detected by palpation, localized swelling, and tender points. Some of the
characteristic trigger points include the upper trapezius, sternocostal and costochondral
junction, manubriosternal junction, the vertebral spinous processes, and the xiphoid process
[8]. For AS patients, active disease means pain, mobility restriction, muscle tension, inability
to stay supine, restriction in chest mobility, dyspnea, disturbed sleep, and difficulty to breathe
[6, 9].
__Progressive ankylosis of the thoracic spine in AS will eventually lead to restrictive
pulmonary function impairment, characterized by reduced vital capacity (VC), increased ratio
of forced 1-s expiratory volume (FEV1) and forced vital capacity (FVC). Respiratory function
in AS shows a typical restrictive pattern, which is characterized by decrease of FVC <80%
and FEV1 with normal FEV1/FVC ratio [1, 7, 10].
__Both pharmacological treatment with primarily tumor necrosis factor-α (TNF-α) inhibitors
and complex physical exercise are effective and important [11, 12, 13]. Anti-TNF agents are
particularly effective during the early, inflammatory stages of the disease [4, 11]. Biologics
are able to decrease inflammatory pain and muscle stiffness, and improve functional capacity,
mobility and quality of life [11]. Physical therapy may have additive value by maintaining
or even improving mobility, fitness, and general health. It also plays an important role in the
prevention and management of the deformities related to AS [13, 14].
__In our previous study we analyzed 75 AS patients from the point of view of gender
differences and they did not show obvious variances [15]. Therefore in the current study (I),
we retrospectively examined the same patients being on the basis therapy whether there are
differences of physical and certain functional parameters between patient with or without
biological therapy, and (II) prospectively, in a small, volunteer group of AS patients treated
with biological we assessed the effects of a targeted physical therapy program on chest pain,
tenderness, mobility, and respiratory function. It was hypothesized that AS patients receiving
biological therapy may have further benefit from a targeted physical therapy program.
Patients and methods
Study design and patients
Study 1 (retrospective analysis)–Clinical data of AS patients with biological therapy (n=55)
or without biological therapy (n=20) were retrospectively analyzed and compared at the
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Department of Rheumatology, Medical and Health Sciences Center, University of Debrecen.
All patients had definite AS according to the modified New York criteria [16]. Informed
consent was obtained from all participants. Anthropometrical data, time since diagnosis
and patient assessment of disease activity, functional capacity, BASDAI (Bath Ankylosing
Spondylitis Disease Activity Index) and BASFI (Bath Ankylosing Spondylitis Functional
Index), pain intensity on a VAS (visual analog scale), drugs history, sacroiliitis stage assessed
by X-ray, and levels of physical activity were recorded. Functional and physical tests were
performed by the same physician as described below. None of the patients had a history of
cardiopulmonary diseases.
Study II (prospective, self-coontrolled analysis)–Of the 55 AS patients with biological
therapy described above, 10 volunteered for this study (6 men with age of 55.2±13.32 years
and 4 women with age of 48.25±14.97 years). This part was based on a prospective,
nonrandomized physiotherapeutic intervention, including a targeted physical therapy program.
The participation was voluntary. All 55 patients of study I were contacted by mail, which had
been sent twice. A total of 17 patients were interested in the program, but because of familial
and logistical reasons, only 10 patients could complete the study. Informed consent was
obtained from all participants. Age, height, weight, disease duration, drug history, radiological
stage, and physical activity level were recorded.
The physical examinations were performed by the same physician (N.B.) before and after the
targeted therapy program. All patients had recent respiratory function tests and these were
repeated. None of the patients had any overt cardiopulmonary diseases.
Biological therapy
All patients with biological therapy (study I and II) had received etanercept or infliximab
according to standard of care for at least 3 months prior to the study [11].
Physical therapy
The physical therapy program included conventional exercise, global posture reeducation,
breathing exercises, manual mobilization of the chest, stretching of the shortened muscles
(back, lumbar spine, around hip and shoulder), and functional exercises with joint prevention
strategies.
Manual mobilization of the chest–During expiration, in the supine or sitting position, we
asked the patients to place the hands over the ribs and pull the chest diagonally toward■ the
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umbilicus, paying attention to the movements of the ribs. The expiration should not have been
with force and the mouth should have been open. We instructed the patients with following
words: “Take care to have steady and deep breathing!”
Exercise therapy–It could be performed in any position with harmonized movements of the
column and the extremities, always working against the deformity and typical AS posture.
It was important to avoid abdominal exercises which start with chest elevation, because
this would increase kyphosis. These exercises include not only of breathing harmonization
but play also an important role in joint mobilization. During the exercises, inspiration was
at the starting position, while expiration means the shifting toward the end position. The
movements of the column and the chest could be combined with the action of the upper and
lower extremities, producing complex exercise. Besides the column’s elongation, we focused
on tilting of the hip and on the scapula stabilization. The complex exercises, made in a closed
kinematic chain, increase muscle elongation.
__The full exercise program took 1.5 h and was performed twice a week for 12 weeks (a total
of 24 treatments). During the first 4 weeks, an individualized physical therapy program was
conducted, while during the following 8 weeks physical therapy was applied in groups of 2–
3 patients.
Clinical assessments
For the assessment of functional ability and disease activity, the BASFI and BASDAI [17]
were recorded. In study II the tests have been completed before and after the 12-week
physical therapy program.
__Participants were assessed in a clinic-based setting by a trained observer (N.B.). Chest
expansion, modified Schober Index, lateral flexion, occiput-to-wall distance, and fingertip-to-
floor distance were measured. Each movement had been practiced once before the range of
motion was recorded. All baseline and repeat appointments were arranged for the same time.
Furthermore, tender points were detected.
Respiratory function tests
Respiratory function tests typically show mild restrictive respiratory pattern [1]. Spirometry
was performed completed before and after the 12-week physical therapy program. Forced
vital capacity (FVC), forced expiratory volume during the first second (FEV1), peak
expiratory flow (PEF), and maximum voluntary ventilation (MVV) were assessed and
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recorded. The values were expressed as a percentage of the predicted normal values according
to the European Respiratory Society criteria [17].
Statistical analysis
Differences were evaluated by using paired t-test or Wilcoxon signed rank test, depending on
the normality of data distribution. The significance level was set at value of p<0.05.
Results
Study I: retrospective analysis of patients with or without biological
therapy
The age, time since diagnosis, and disease activity as well as functional index values of
examined AS patients are summarized in Tab. 1.
__Differences in disease activity (42.28±27.35 vs. 56.67±25.99; p=0.019) and pain intensity
(39.53±25.76 vs. 51.42±24.7; p=0.017) between the groups were found. Degree of the
occiput-to-wall distance, the posture and spine bendings were better in biological therapy
group. Pain and tenderness of the thoracic spine were observed in both groups. The back pain
without biologic therapy was slightly higher than other group (Fig. 1).
Fig. 1  In study I, position of pain and tenderness in patients a treated with biologicals and b not
treated with biologicals
Study II: prospective analysis of targeted physiotherapy
In the 10 volunteer AS patients with biological therapy (Tab. 2), assessment of
disease activity, and pain intensity significantly improved after the 12-week targeted
physiotherapeutic program (p=0.002 and p<0.001, respectively; Fig. 2a, b).
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Fig. 2  In study II, the a disease activity, b pain intensity, c Bath Ankylosing Spondylitis Functional
Index (BASFI) and d Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) values before and
after physical therapy. Means ± S.D., n=10; *p<0.05 vs. before or after
__In all cases, improvement in functional parameters and disease activity was observed
after the targeted physical therapy program. Both BASFI and BASDAI increased after
treatment (p=0.004 and p<0.001, respectively; Fig. 2c, d). When analyzing the individual
changes, almost the same ratio was found when evaluating the “before treatment” versus
“after treatment” differences.
__Mobility evaluations also revealed significant improvement. Significantly increased
finger-to-floor distance (p=0,008), chest expansion (p<0.001), and modified Schober Index
(p=0.031) were observed after versus before treatment. The occiput-to wall distance did not
change significantly (Fig. 3). Chest expansion exerted a two-fold increase in the majority of
patients. The lateral flexion increased significantly in both sides (p=0.002 right; p=0.006 left),
developing symmetrical movements.
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Fig. 3  a Modified Schober Index (MSI), b chest expansion (CE), c finger-to-floor distance (FFD), and
d occiput-to-wall distance (OWD) values before and after physical therapy (study II). Means ± S.D.,
n=10; *p<0.05 vs. before or after
__Despite the improvement in mobility and functionality, pulmonary function tests including
FVC, FEV1, PEF, and MVV showed only non-significant tendencies towards improvement
(Fig. 4). There were no obvious individual differences, and the degree of FVC improvement
seemed to be independent of the magnitude of chest expansion.
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Fig. 4  a Forced vital capacity (FVCl), b 1-s forced expiratory volume (FEV1), c peak expiratory flow
(PEF), and d maximum voluntary ventilation (MVV) values before and after physical therapy (study II).
Means ± S.D., n=10
__Tenderness of typical tender points of the chest indicated improvement and decreased
sensitivity to pressure, mainly over the sternocostal, chondrocostal, manubriosternal
junction, and xiphoid process regions. The tenderness of sternocostal and costosternal
junctions decreased remarkably, but the sacroiliacal pain did not influence motion. From
the characterized tender points, the tenderness of the coracoids process, the superior angle
of scapula, the great trochanter, and the ischial tuberosities were marked less after exercise
therapy. The tenderness of spinosus processes—which was provoked with palpation—
decreased, except for the thoracal region. Pain and stiffness of paravertebral muscles showed
improvement with smaller number of markings by the patients (Fig. 5, Fig. 6).
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Fig. 5  Number of markings for tenderness of the a chest—fibrocartilagous junctions and b regional
tender points before and after exercise therapy (study II)
Fig. 6  Number of markings for a tenderness of spinosus processes and b stiffness before and after
exercise therapy (study II)
Discussion
In AS, chest pain often occurs as a consequence of costovertebral and costotransverse joint
involvement and might be associated with tenderness over sternocostal and costosternal
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junctions [19, 20]. Pulmonary function abnormalities are due mainly to the restriction of
chest wall movement [21]. Restrictive lung disease occurs in kyphoscoliosis and AS due to
decreased functional residual capacity, inspiratory capacity, lung compliance, and airway
conductance. Some patients reported an inability to expand the chest upon inspiration [13, 21,
22]. The normal chest expansion is 5 cm or greater; however, it is age- and sex-dependent.
Limited chest expansion—in individual insidious onset of chronic low back pain and without
chest disease such as emphysema or scoliosis—should strongly raise the possibility of AS [8].
__Patients in whom disease activity cannot be adequately controlled by conventional
techniques may be treated with biological agents targeting TNF-α, which are now licensed
for treatment of patients with severe AS whose symptoms do not respond adequately to
conventional therapy. Without treatment the spine increasingly stiffens and the peripherial
(mostly large) joints are often destroyed by inflammatory processes. Early diagnosis is
of utmost importance because today treatment with novel drugs is feasible with TNF-α
inhibitors being particularly effective during the early stages of the disease.
__Demonstrated by our patients’ parameters, the inhibition of inflammation led to lower
pain intensity and disease activity, better physical conditions and functionality. In the case
of 55 patients, moderate pain, larger MSI and chest expansion were observed, showing
decreased BASFI and BASDAI values [23, 24, 25, 26, 27]. The limitation of this study part is
its retrospective character.
__Physical therapy applied individually or in groups has general and specific beneficial
effects for patients suffering from AS [28, 29, 30]. Several studies reported improvement in
the wall-to-occiput distance, finger-to-floor distance, chest expansion, Schober Index, and
pulmonary function after a couple of weeks of intensive physiotherapy [1, 14, 31, 32].
__In study II, which was a prospective but nonrandomized self-controlled study, we
investigated functional and physical parameters with respect to the above mentioned
structural–functional changes in AS patients currently receiving anti-TNF therapy. Results
suggested significant improvements in function and mobility.
__Our physical exercise program included elements of conventional and breathing exercises
as well as global posture reeducation. The stretching theories also played an important role,
adapted for the alterations in the column and the chest. The conventional exercises focus
on mobilization of the great joints and on strengthening of the shoulder and hip complex
muscles. The aim of the breathing exercises is mobilization of the joints in the spinal column
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and chest, together with development of appropriate breathing mechanics, while the basics
of global posture reeducation are spine elongation and hip complex position according to
biomechanical analyses [1, 8, 12, 13, 17].
__We observed improvements in finger-to-floor distance and thoracolumbar lateral flexion,
slightly in modified Schober Index, while the occiput-to-wall distance did not change
markedly. The finger-to-floor distance depends on the extensibility of hamstring muscles
and the thoracolumbar lateral flexion is influenced by the extensibility of spine muscles. The
occiput-to-wall distance is defined by curvature and mobility of the spine, tilt of the pelvis,
and stiffness around the hip and spine [20, 33]. Normal chest expansion requires normal
costovertebral, costosternal, manubriosternal, and sternoclavicular joints. If any of these joints
are involved, chest expansion is diminished [7, 10, 19]. Our results also showed associations
of pain, numbers of tender points, chest expansion, and thoracolumbar lateral flexion.
__Durmuş et al. [34] compared the effects of conventional exercise and global posture
reeducation (GPR). There were significant improvements for BASDAI and BASFI scores
in all groups, significant improvements in the VAS pain, chest expansion, but the GPR
method resulted in greater improvements than the conventional exercise program in specific
pulmonary function parameters like forced vital capacity, forced expiratory volume in 1 s, and
peak expiratory flow parameters.
__Previously, the pulmonary function tests of our patients had shown that the typical
pattern was restrictive, characterized by low chest expansion and lateral flexion. The
restrictive pattern characterized by low FVC is frequently associated with a decreased
thoracic expansion [7, 10]. After 12 weeks of targeted physical therapy, respiratory function
improved slightly, but not significantly—probably because this program did not contain direct
cardiopulmonary exercises. Physical therapy included manual mobilization and breathing
exercise, and so these techniques could not ameliorate breathing muscle endurance. The
muscles’ endurance and response to differenct exercises decrease in AS, which correlated
significantly with age, disease duration, chest expansion, modified Shober Index, and vital
capacity [35, 36, 37].
__Karapolat et al. [38] found that swimming, walking, and conventional exercise (CE)
had beneficial effects on quality of life and pulmonary function. Aerobic exercises such as
swimming and walking in addition to CE significantly increased functional capacities of
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patients. However, no significant differences were detected in the exercise groups with regard
to BASDAI and BASFI.
__Koseoglu et al. [22] also reported that the exercise training improves some of the spinal and
respiratory limitation in AS; however, exercise training, as part of pulmonary rehabilitation,
was not sufficient evidence for effectiveness. Comparing with the values recorded at the
beginning of the study, they observed slight increases in FVC, FEV1, and MVM. Our results
correspond nicely with these observations; however, they also found a significant correlation
between FVC, chest expansion, and lumbar flexion.
__Ortancil et al. [39] applied a 6-week home-based program, using breathing and upper
extremity exercises. In their study, chest expansion, pulmonary function, and BASFI scores
significantly improved. In our study, significant improvement of BASFI and BASDAI
scores were also found. Sahin et al. [21] suggested a significant negative correlation between
functionality and pulmonary muscle strength, but they did not find a significant relation
between BASFI and chest expansion.
__Enthesitis is inflammation at the insertion point of ligaments, tendons, joint capsule, or
fascia to bone, and a well-known characteristic of AS. Entheseal pain may be mild, moderate,
severe, or disabling and, there is a correlation with disease activity, tenderness, and number of
tender points [40, 41].
__Back pain and stiffness were dominant in these 75 AS patients. Lower back pain is
dependent on inflammatory activity of sacroiliac joints; in particular ankylosis correlates
with limited range of motion (ROM), paravertebral stiffness, and the inflammation at the
intervertebral, costovertebral, costotransversal joints and fibrocartilagous junctions, which
increase pain.
__As the result of targeted exercise therapy (in study II), the tenderness of cervical and
thoracic spinosus processes decreased, but was stagnant in the thoracic region, whereas
motion did not influence the inflammatory process and ragiological conditions [42]. The
degree of pain and tenderness correlate with patient assessment of disease activity. The
paravertebral region was activated by exercises; therefore, muscles pain and stiffness
decreased. Exercise with stretching resulted in favorable structural transformation in
muscles (the number of sarcomers increased) and pain decreased [43, 44]. The tenderness of
fibrocartilagous junctions showed the greatest improvement.
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__Beside targeted physiotherapy which includes adapted exercise therapy, biological agents
are highly effective in the therapy of AS. Because of the locomotor manifestations of the
disease, stimulation of motion is indispensable in therapy, which can improve mobility and
function, supplementing the targeted therapy.
__The results of our and previous studies showed that AS patients receiving biological
therapy and additional physiotherapy may show remarkable improvement. We suggest
that physical therapy has an important and additive role in the complex therapy of AS. For
this purpose, a targeted exercise program may contribute to joint protection strategies and
pharmacological treatment.
__The ratio of the volunteers (17 of 55 patients, 30.9%; those who completed the program
10 of 55 patients, 18.18%) was very low in our study. This may indicate low motivation of
patients for physical activity and exercises in addition to logistic reasons. According to these
preliminary results, we are encouraged to continue the studies with this physical exercise
combination and increasing the case number for new studies.
Conclusion
Physical therapy may be of important additive value in AS patients being treated with
biologicals. Our exercise program improved functional parameters as well as spine and chest
mobility, thus, enhancing the positive effects of biological therapy.
__Key messages are
– complex physiotherapy, in addition to biologics, may improve ankylosing spondylitis,
– a targeted physiotherapy program improved pain intensity, and
– physiotherapy improved chest mobility and respiratory function.
Conflict of interest–No statement made.
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Tab. 1  Patients’ data in study I with or without biological therapy
GroupsParameters
With biological therapy (n=55) Without biological therapy (n=20)
Age (years) 44.23±10.59 46.35±10.2
Disease duration since diagnosis (years) 14.4±10.56 16.15±10.75
Degree of sacroiliitis 3.3±0.89 2.89±1.13
Disease activity (cm on VAS) 42.28±27.35 56.67±25.99*
Pain intensity (cm on VAS) 39.53±25.76 51.42±24.7*
BASFI (cm on VAS) 4.49±2.87 4.89±2.95
BASDAI (cm on VAS) 3.63±2.46 4.58±2.29
Modified Schober Index (cm) 2.64±1.93 2.18±2.01
Occiput-to-wall distance (cm) 6.6±8.14 9.83±9.06
Chest expansion (cm) 2.8±1.29 2.45±1.22
Mean ± S.D., *p<0.05 vs. group with biological therapy.VAS visual analog scale, BASFI Bath Ankylosing Spondylitis Functional Index, BASDAI Bath Ankylosing Spondylitis Disease Activity Index.
– 22 –
Tab. 2  Summary of patients’ data taking part in study II
Age (years) 52.4±13.64
Height (cm) 167±12.79
Weight (kg) 76.2±15.5
Disease duration (years) 16.1±13
SI average stage 3.4±0.8
Biologic therapy duration (years) 1.8±0.75
Means ± S.D., n=10
